AdvVEGF-D

VEGF-D gene therapy using an adenoviral vector · Kuopio University Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AdvVEGF-D, covering 2025-01-13 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris [Phase 2]

See pricing